Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
A comparative analysis of Denosumab (DMAB) and Zoledronic Acid (ZA) was conducted in a real-world cohort of 864 patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer with bone metastases, who were undergoing CDK4/6 inhibitors plus endocrine...
Saved in:
Similar Items
-
A Case of Isolated Left Ventricular Noncompaction with Basal ECG-Tracing Strongly Suggestive for Type-2 Brugada Syndrome
by: Maria Banci, et al.
Published: (2011-01-01) -
A Step-by-Step Harmonization Process for Nutritional Epidemiology Purposes: A Methodological Work of the Collaborative PROMED-COG Pooled Cohorts Study
by: Federica Prinelli, et al.
Published: (2023-11-01) -
Metodi e strumenti informativo-rappresentativi per il progetto strategico Smart Swap Building. Validazione di una filiera digitale a supporto dell’innovazione di processo per la riqualificazione del patrimonio residenziale
by: Marco Medici, et al.
Published: (2016-06-01) -
Ultrastructural insights into early myoblast differentiation induced by shockwave stimulation
by: Larisa Ryskalin, et al.
Published: (2025-07-01) -
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics
by: Sara Manti, et al.
Published: (2025-03-01)